Category Technical Cooperation/ Technology Transfer

Industrial Designs Still On Track To Treaty At WIPO, Despite Differing Views

World Intellectual Property Organization delegates advanced work on a draft treaty text on industrial design this week but were left divided on the opportunity of holding a high-level meeting to adopt such a treaty in 2014. One of the sticking points was whether to include an article on technical assistance and capacity building in the text of the draft treaty. The committee also decided to continue work on the protection of country names in the context of trademarks.

Country Names An Easier Road Than Technical Assistance For WIPO Trademark Committee

The protection of country names was discussed today by World Intellectual Property Organization members with a more amiable approach than on how to include technical assistance in a draft treaty text on industrial designs. The question of the convening of a high-level meeting to adopt the potential treaty was also discussed with dissension between developing and developed countries.

World Health Assembly: IP Considerations Play Key Role In Final Outcomes

Wrapping up one day early, the 66th World Health Assembly adopted a range of public health resolutions and decisions, some with key intellectual property implications, including a decision to convene a technical meeting on new public health R&D projects, a compromise on advancing the poor quality medicines mechanism, and resolutions on both neglected tropical diseases and noncommunicable diseases. Importantly, the novel coronavirus situation drew attention to WHO’s progress in pandemic influenza preparedness.

World Health Assembly: Pandemic Flu Framework Clears Committee

Member states gathered at the annual World Health Assembly took note of a report on its pandemic influenza preparedness (PIP) framework amid encouragement by developed countries that standard agreements for transferring materials be completed, and reminders from some developing countries of the need for fair access and benefit-sharing of the resulting treatments.

Focus On Quality For Patients Saves Billions Of Dollars

Daniela Bagozzi writes: Ten years of efforts in treatment for priority diseases has yielded impressive results both in terms of lives and dollars saved. To maintain progress in a volatile and financially tight environment countries and the international community will need to increase pressure on quality and healthy generic competition.